Dewey Julie D. 4

Accession 0001235802-19-000134

CIK 0001492658other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:52 PM ET

Size

40.6 KB

Accession

0001235802-19-000134

Insider Transaction Report

Form 4

Period: 2019-11-18

Wright Medical Group N.V.WMGI

TRACY JULIE D

SVP & Chief Commun. Officer

Transactions

Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$23.93/sh+8,232$196,992→ 61,218 total
Sale
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$29.49/sh−119,969$3,538,342→ 26,558 total
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−8,232→ 0 total
Exercise: $23.93Exp: 2023-05-14→ Ordinary Shares (8,232 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−6,983→ 5,443 total
Exercise: $27.86Exp: 2027-07-25→ Ordinary Shares (6,983 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$20.75/sh+7,324$151,973→ 51,210 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$20.62/sh+54,437$1,122,491→ 115,655 total
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−16,341→ 0 total
Exercise: $17.79Exp: 2021-10-17→ Ordinary Shares (16,341 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−7,324→ 0 total
Exercise: $20.75Exp: 2022-05-09→ Ordinary Shares (7,324 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−19,997→ 4,642 total
Exercise: $21.24Exp: 2026-07-19→ Ordinary Shares (19,997 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$17.70/sh+987$17,470→ 43,886 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$21.24/sh+19,997$424,736→ 135,652 total
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−987→ 0 total
Exercise: $17.70Exp: 2022-04-16→ Ordinary Shares (987 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−1,776→ 0 total
Exercise: $22.55Exp: 2023-04-17→ Ordinary Shares (1,776 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−54,437→ 0 total
Exercise: $20.62Exp: 2025-10-13→ Ordinary Shares (54,437 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-18−3,892→ 8,568 total
Exercise: $24.49Exp: 2028-07-24→ Ordinary Shares (3,892 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$17.79/sh+16,341$290,706→ 42,899 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$22.55/sh+1,776$40,049→ 52,986 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$27.86/sh+6,983$194,546→ 142,635 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-18$24.49/sh+3,892$95,315→ 146,527 total

Footnotes (7)

[F1]Exercise and sale of vested stock options in connection with 280G tax planning.
[F2]Includes 2,144 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,588 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,616 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.51, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
[F4]This option has fully vested.
[F5]This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
[F6]This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
[F7]This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Wright Medical Group N.V.

CIK 0001492658

→

Entity typeother

Related Parties

filerCIK 0001218011

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 4:52 PM ET
Size: 40.6 KB

View on SEC.gov